Author

M. X. Li

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:mouse· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

B. Feng· 1 shared B. J. Smith· 1 shared B. Zhang· 1 shared C. Dai· 1 shared C. f. Huang· 1 shared C. Hu· 1 shared C. Jin· 1 shared C. Zhang· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Feng

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular definition of the BAK:VDAC2 interaction as a target to manipulate apoptosis

Z. Yuan, M. F. van Delft, M. X. Li, F. Sumardy, B. J. Smith, D. C. S. Huang, G. Lessene, Y. Khakham, R. Jin, S. He, N. A. Smith, R. Birkinshaw, P. E. Czabotar, G. Dewson

This study identifies key residues in the BAK:VDAC2 interaction, showing that disrupting this interaction can inhibit or promote apoptosis depending on the context.

bioRxiv · Dec 13, 2023 · PreprintCell Biology

Immuno-Engineered Mitochondria for Efficient Therapy of Acute Organ Injuries via Modulation of Inflammation and Cell Repair

Q. Zhang, Y. Shen, H. Zhang, S. Yang, M. X. Li, C. Dai, X. Yu, J. Lou, C. Zhang, J. Feng, C. Hu, Z. Lin, X. Li, X. Zhou

This study develops nMITO, engineered mitochondria that target inflammation and repair in acute organ injuries, showing efficacy in mouse models of myocardial, liver, and pancreatitis injuries.

bioRxiv · Jun 12, 2023 · PreprintBioengineering

Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro

C. Jin, B. Feng, R. j. Pei, Y. q. Ding, M. x. Li, X. Chen, Z. y. Du, Y. x. Ding, C. f. Huang, B. Zhang, X. w. Chen, Y. Zang, J. Li, K. Ding

This paper identifies a novel pectin from Syzygium aromaticum that strongly inhibits SARS-CoV-2 replication by binding to 3CLpro, PLpro, and RdRp enzymes.

bioRxiv · Oct 27, 2021 · PreprintPharmacology & Toxicology